[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368373-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-368373-en":135},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","inhibition-of-the-long-non-coding-rna-malat1-downregulates-map2k1-suppressing-the-progression-of-hypopharyngeal-squamous-cell-carcinoma","Inhibition of the long non-coding RNA MALAT1 downregulates MAP2K1, suppressing the progression of hypopharyngeal squamous cell carcinoma","","Study investigates the role of lncRNA MALAT1 and its mechanism in hypopharyngeal squamous cell carcinoma (HSCC). qRT-PCR quantifies MALAT1 and MAP2K1 in HSCC and adjacent tissues, while Cox regression evaluates prognostic value. MALAT1 downstream candidates are screened by PRM and TCGA-HNSC, then confirmed by Western blotting and immunohistochemistry. Functional assays (CCK-8, flow cytometry, Transwell) and nude mouse xenografts show that MALAT1 inhibition suppresses proliferation, migration, EMT, apoptosis, and tumor growth through downregulation of MAP2K1.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/inhibition-of-the-long-non-coding-rna-malat1-downregulates-map2k1-suppressing-the-progression-of-hypopharyngeal-squamous-cell-carcinoma/368373/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/inhibition-of-the-long-non-coding-rna-malat1-downregulates-map2k1-suppressing-the-progression-of-hypopharyngeal-squamous-cell-carcinoma/368373.png","ImageObject",300,407,{"name":42,"@type":43},"Valentina","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-10","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What was the primary goal of the study?","Question",{"text":63,"@type":64},"To determine how lncRNA MALAT1 contributes to HSCC and to clarify the mechanism involving downstream regulation of MAP2K1 and cancer progression.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the researchers evaluate MALAT1 and MAP2K1 expression and clinical relevance?",{"text":68,"@type":64},"They used qRT-PCR to measure MALAT1 and MAP2K1 in HSCC and adjacent tissues, and Cox regression analysis to assess the independent prognostic significance of MALAT1.",{"name":70,"@type":61,"acceptedAnswer":71},"What downstream target was identified for MALAT1, and how was it validated?",{"text":72,"@type":64},"MAP2K1 was identified as a potential downstream target using PRM screening and TCGA-HNSC data, then validated by qPCR, Western blotting, and immunohistochemistry.",{"name":74,"@type":61,"acceptedAnswer":75},"What effects did MALAT1 inhibition have on HSCC progression?",{"text":76,"@type":64},"In vitro and in vivo experiments showed that MALAT1 inhibition suppressed proliferation, migration, EMT, apoptosis-related behaviors, cell-cycle effects, and tumor growth by downregulating MAP2K1.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},368373,1790211004,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,131],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":128,"slug":130},10,"Lifestyle","lifestyle",{"id":132,"doc_module":4,"doc_module_name":25,"category_name":133,"show_sort_weight":101,"slug":134},19,"General","general",{"code":4,"msg":86,"data":136},{"doc_id":83,"user_id":137,"nickname":42,"user_avatar":138,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":144,"language":145,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":12,"update_tm":149,"read_time":150,"preview_page_count":33,"preview_urls":151},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","RESEARCH ARTICLE  \nInhibition of the long non-coding RNA MALAT1 downregulates MAP2K1, suppressing the progression of hypopharyngeal squamous cell carcinoma  \nXiaomin Wang 1, 2\\#, Hui Li 1, 2\\#, Aoxuan Xu 2, Jie Peng 2, Yanqing Wu 2, Yunfan Liu 2, Junjie Zhang 2, Changqi Cai 2, Shiyin Ma 2 ∗, and Kai Zhang 1, 3 ∗  \nThis study aimed to explore the role of long non-coding RNAs metastasis-associated lung adenocarcinoma transcript (lncRNA MALAT1), and its underlying mechanisms in hypopharyngeal squamous cell carcinoma (HSCC). Quantitative real-time PCR (qRT-PCR) was employed to measure lncRNA MALAT1 expression in HSCC and adjacent non-cancerous tissues, along with the expression of the downstream target mitogen-activated protein kinase kinase 1 (MAP2K1). The independent prognostic significance of lncRNA MALAT1 was assessed using Cox regression analysis. Potential downstream targets of MALAT1 were identified through parallel reaction monitoring (PRM) analysis and validated using the TCGA-HNSC database, Western blotting, and immunohistochemistry. CCK-8, flow cytometry, and Transwell assays were conducted to assess the effects ofthe lncRNA MALAT1/MAP2K1 axis on FaDu cells. Additionally, a nude mouse xenograft model was used to confirm the role of lncRNA MALAT1/MAP2K1 in tumor growth. LncRNA MALAT1 was significantly upregulated in HSCC tissues and closely associated with poor prognosis. Bioinformatics analysis, including PRM screening and TCGA-HNSC data, identified FERMT2, CSNK2A2, and MAP2K1 as potential downstream targets of MALAT1. Validation through qPCR, Western blotting, and immunohistochemistry confirmed MAP2K1 as a downstream target. In vitro and in vivo experiments demonstrated that inhibiting lncRNA MALAT1 suppressed cell proliferation, migration, and epithelial-to-mesenchymal transition (EMT) by downregulating MAP2K1 expression. Additionally, it induced apoptosis, affected the cell cycle, and inhibited tumor growth. Our study uniquely demonstrates that targeting MALAT1 significantly impedes HSCC progression by downregulating its novel downstream target, MAP2K1, offering new insights into potential therapeutic strategies.  \nKeywords: lncRNA, MALAT1, MAP2K1, hypopharyngeal squamous cell carcinoma, progression.  \nIntroduction  \nHypopharyngeal squamous cell carcinoma (HSCC) is oneof the most aggressive head and neck malignancies, with ﬁve-year survival rates ranging from 30% to 50% [1, 2] . Early-stage HSCC is often asymptomatic due to its hidden location, leading to frequent metastasis to cervical lymph nodes [3] . Standard treatments—surgery, radiotherapy, and chemotherapy—oﬀer limited survival beneﬁts, particularly for patients with intermediate and advanced stages [4, 5] . In recent years, immunotherapy and targeted therapy have emerged as promising options for patients with advanced recurrence and metastasis, although their applicability remains limited [6] . Accumulating evidence implicates multiple genes and functional RNAs in the complex molecular regulation of HSCC [7] . Further understanding of the mechanisms driving HSCC ini-  \ntiation, progression, and immune evasion is essential for identifying reliable prognostic biomarkers and improving therapeutic strategies.  \nLong non-coding RNAs (lncRNAs), which are RNA molecules over 200 nucleotides in length, play signiﬁcant roles in cellular biology [8] . Among them, lncRNA metastasis-associated lung adenocarcinoma transcript (MALAT1) has been implicated in the pathogenesis of various cancers [9], including esophageal [10], cervical [11], and laryngeal cancers [12], where it inﬂuences tumor cell proliferation, apoptosis, invasion, and metastasis [13]. However, conﬂicting ﬁndings regarding its underlying mechanisms have been reported in the literature [14] . Previous investigations by our group identiﬁed upregulated expression of lncRNA MALAT1 in laryngeal squamous cell carcinoma tissues, closely correlating with patient  \n1Anhui Medical University, Hefei, China; 2 Departmen","cbCaidJQmrRBR7ZD","https://ap.wps.com/l/cbCaidJQmrRBR7ZD","pdf",6026152,15,"English","# Introduction\n## Long non-coding RNA MALAT1 in cancer biology\n## MAP2K1 and the MAPK signaling pathway\n# Methods overview\n## Expression assays and prognosis analysis\n## Target identification and validation\n## Functional assays and in vivo xenografts\n# Results summary\n## MALAT1 upregulation and poor prognosis\n## MAP2K1 as a MALAT1 downstream target\n## Effects of MALAT1 inhibition on cell behavior and tumor growth\n# Conclusion","[{\"question\":\"What was the primary goal of the study?\",\"answer\":\"To determine how lncRNA MALAT1 contributes to HSCC and to clarify the mechanism involving downstream regulation of MAP2K1 and cancer progression.\"},{\"question\":\"How did the researchers evaluate MALAT1 and MAP2K1 expression and clinical relevance?\",\"answer\":\"They used qRT-PCR to measure MALAT1 and MAP2K1 in HSCC and adjacent tissues, and Cox regression analysis to assess the independent prognostic significance of MALAT1.\"},{\"question\":\"What downstream target was identified for MALAT1, and how was it validated?\",\"answer\":\"MAP2K1 was identified as a potential downstream target using PRM screening and TCGA-HNSC data, then validated by qPCR, Western blotting, and immunohistochemistry.\"},{\"question\":\"What effects did MALAT1 inhibition have on HSCC progression?\",\"answer\":\"In vitro and in vivo experiments showed that MALAT1 inhibition suppressed proliferation, migration, EMT, apoptosis-related behaviors, cell-cycle effects, and tumor growth by downregulating MAP2K1.\"}]","Inhibition of the long non-coding RNA MALAT1 downregulates MAP2K1, suppressing the progression of hypopharyngeal squamous cell carcinoma | PDF",1790176582,38,[152,156,160,164],{"page_no":22,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ef6ca85442daea7e41d062a4b1bdb45.webp",983,1272,{"page_no":26,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2ad99467c1b95a2f75a7309f6cd04c9b.webp",982,1270,{"page_no":30,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1cb8ea90e41230732fd6942cc84ae474.webp",981,1269,{"page_no":33,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b242ae581d432cb51e0e13d6f33eede1.webp",980,1268]